Literature DB >> 19444453

Association of anti-CCP positivity with serum ferritin and DAS-28.

Burcu Önder1, Aydan Kurtaran, Songül Kimyon, Barin Selçuk, Müfit Akyüz.   

Abstract

Antibodies to cyclic citrullinated peptides (anti-CCP) are highly specific for the diagnosis of rheumatoid arthritis (RA) with a marginal increased prediction of the disease. In this study, we aimed to investigate the relation of the presence of anti-CCP with clinical manifestations and disease activity in a cohort of RA patients. A total of 61 RA patients were included in this study. Data of disease-related parameters such as duration of disease, medications, degree of pain (visual analog scale, VAS), disease activity score 28 (DAS-28) and health assessment questionnaire (HAQ) were recorded. Laboratory workup included erythrocyte sedimentation rate (ESR), plasma C-reactive protein (CRP), rheumatoid factor (RF), anti-CCP, complete blood count and anemia parameters. Anti-CCP positivity was associated with higher scores of DAS-28, longer duration of morning stiffness, serum RF positivity and low levels of serum ferritin, while it was not associated with disease duration, VAS, HAQ, ESR, CRP and hemoglobin.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19444453     DOI: 10.1007/s00296-009-0941-4

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  37 in total

1.  Guidelines for the management of rheumatoid arthritis: 2002 Update.

Authors: 
Journal:  Arthritis Rheum       Date:  2002-02

2.  Occurrence of extraarticular disease manifestations is associated with excess mortality in a community based cohort of patients with rheumatoid arthritis.

Authors:  Carl Turesson; W Michael O'Fallon; Cynthia S Crowson; Sherine E Gabriel; Eric L Matteson
Journal:  J Rheumatol       Date:  2002-01       Impact factor: 4.666

3.  Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis.

Authors:  M L Prevoo; M A van 't Hof; H H Kuper; M A van Leeuwen; L B van de Putte; P L van Riel
Journal:  Arthritis Rheum       Date:  1995-01

4.  The dimensions of health outcomes: the health assessment questionnaire, disability and pain scales.

Authors:  J F Fries; P W Spitz; D Y Young
Journal:  J Rheumatol       Date:  1982 Sep-Oct       Impact factor: 4.666

5.  Diagnostic accuracy of the anti-citrulline antibody assay for rheumatoid arthritis.

Authors:  N Bizzaro; G Mazzanti; E Tonutti; D Villalta; R Tozzoli
Journal:  Clin Chem       Date:  2001-06       Impact factor: 8.327

6.  Autoantibodies in rheumatoid arthritis: association with severity of disease in established RA.

Authors:  Sumeet Agrawal; Ramnath Misra; Amita Aggarwal
Journal:  Clin Rheumatol       Date:  2006-03-30       Impact factor: 2.980

7.  The prognostic value of anti-cyclic citrullinated peptide antibody in patients with recent-onset rheumatoid arthritis.

Authors:  E J Kroot; B A de Jong; M A van Leeuwen; H Swinkels; F H van den Hoogen; M van't Hof; L B van de Putte; M H van Rijswijk; W J van Venrooij; P L van Riel
Journal:  Arthritis Rheum       Date:  2000-08

8.  Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritis-specific autoantibodies.

Authors:  G A Schellekens; B A de Jong; F H van den Hoogen; L B van de Putte; W J van Venrooij
Journal:  J Clin Invest       Date:  1998-01-01       Impact factor: 14.808

9.  Expression and activity of citrullinating peptidylarginine deiminase enzymes in monocytes and macrophages.

Authors:  E R Vossenaar; T R D Radstake; A van der Heijden; M A M van Mansum; C Dieteren; D-J de Rooij; P Barrera; A J W Zendman; W J van Venrooij
Journal:  Ann Rheum Dis       Date:  2004-04       Impact factor: 19.103

10.  A combination of autoantibodies to cyclic citrullinated peptide (CCP) and HLA-DRB1 locus antigens is strongly associated with future onset of rheumatoid arthritis.

Authors:  Ewa Berglin; Leonid Padyukov; Ulf Sundin; Göran Hallmans; Hans Stenlund; Walther J Van Venrooij; Lars Klareskog; Solbritt Rantapää Dahlqvist
Journal:  Arthritis Res Ther       Date:  2004-05-11       Impact factor: 5.156

View more
  8 in total

1.  Variable association of anti-CCP positivity with serum ferritin may be corrected by APF test.

Authors:  Duck-An Kim; Think-You Kim
Journal:  Rheumatol Int       Date:  2009-09-25       Impact factor: 2.631

2.  Serum anti-cyclic citrullinated peptide antibodies may predict disease activity in rheumatoid arthritis.

Authors:  Kamal Esalatmanesh; Raika Jamali; Arsia Jamali; Bardia Jamali; Mohammadreza Nikbakht
Journal:  Rheumatol Int       Date:  2011-12-21       Impact factor: 2.631

3.  The continuous measurement of anti-CCP-antibodies does not help to evaluate the disease activity in anti-CCP-antibody-positive patients with rheumatoid arthritis.

Authors:  Thoren Landmann; Gabriele Kehl; Raoul Bergner
Journal:  Clin Rheumatol       Date:  2010-09-14       Impact factor: 2.980

4.  Utility of serum ferritin and soluble interleukin-2 receptor as markers of disease activity in childhood systemic lupus erythematosus.

Authors:  Nora Almutairi; Alwaleed Aljaser; Abdulaziz Almutairi; Manal Alshaikh; Abdelmoneim Eldali; Sulaiman M Al-Mayouf
Journal:  Int J Pediatr Adolesc Med       Date:  2019-07-17

5.  Clinical and laboratory factors associated with interstitial lung disease in rheumatoid arthritis.

Authors:  José Félix Restrepo; Inmaculada del Rincón; Daniel F Battafarano; Roy W Haas; Merced Doria; Agustín Escalante
Journal:  Clin Rheumatol       Date:  2015-08-09       Impact factor: 2.980

6.  Anticyclic citrullinated peptide antibody and rheumatoid factor in south Tunisian patients with rheumatoid arthritis: association with disease activity and severity.

Authors:  Mariem Ben Hamad; Sameh Marzouk; Neila Kaddour; Hatem Masmoudi; Faiza Fakhfakh; Ahmed Rebai; Zouhir Bahloul; Abdellatif Maalej
Journal:  J Clin Lab Anal       Date:  2013-12-27       Impact factor: 2.352

7.  Diagnostic issues in difficult-to-treat rheumatoid arthritis: a systematic literature review informing the EULAR recommendations for the management of difficult-to-treat rheumatoid arthritis.

Authors:  Nadia M T Roodenrijs; Melinda Kedves; Attila Hamar; György Nagy; Jacob M van Laar; Désirée van der Heijde; Paco M J Welsing
Journal:  RMD Open       Date:  2021-01

8.  The Relationship of Cytokines IL-13 and IL-17 with Autoantibodies Profile in Early Rheumatoid Arthritis.

Authors:  Isabela Siloşi; Mihail Virgil Boldeanu; Manole Cojocaru; Viorel Biciuşcă; Vlad Pădureanu; Maria Bogdan; Ramona Georgiana Badea; Carmen Avramescu; Ileana Octavia Petrescu; Florin Petrescu; Cristian A Siloşi
Journal:  J Immunol Res       Date:  2016-08-04       Impact factor: 4.818

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.